Nuvation Bio Inc Revenue per Employee (NUVB), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Nuvation Bio Inc   (NYSE: NUVB)
 

Nuvation Bio Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 644.35% in the second quarter 2026, year on year to cumulative value of $170 million, Nuvation Bio Inc 's revenue per employee grew on a trailing twelve months basis to $ 3,943,047, this marks a new company high.
Within the Healthcare sector Employees of 18 other companies have achieved higher revenue per employee. While Nuvation Bio Inc 's total ranking has deteriorated compared to the previous quarter from 115 to 276. Nuvation Bio Inc has 43 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NUVB Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 644.35 % 2683.55 % 544.57 % 5924.06 % 291.27 %
Sales per Employee (TTM) $ 3,943,047 3,305,140 1,439,140 616,581 324,512
NUVB's Total Ranking # 276 # 115 # 512 # 498 # 1941
Seq. Revenue Change -61.93 % 98.8 % 227.81 % 200 % 42.37 %

NUVB Company Profile >> Back to NUVB Efficiency Comparisons >> Compare NUVB Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 11
Healthcare Sector # 19
Overall Market # 276

Revenue per Employee Statistics
High Average Low
$ 3,943,047 $ 1,646,539 $ 250,814
(Jun 30 2026)   (Mar 31 2025)



Financial Statements
Nuvation Bio Inc 's Revenue MRQ $ 32 Millions Visit NUVB's Income Statement
Nuvation Bio Inc 's Revenues TTM $ 170 Millions Visit NUVB's aggregate revenue growth
What are NUVB's Sales? Visit NUVB's Sales by Segment




Other Ratios
Nuvation Bio Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
NUVB's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for NUVB's Competitors
Revenue per Employee for NUVB's Suppliers
Revenue per Employee for NUVB's Customers

You may also want to know
NUVB's Sales Growth Rates NUVB's Pe Price to earnings ratio NUVB's Receivables Turnover Ratio NUVB's Stock Quote
NUVB's Net Income Growth Rates NUVB's Ps Price to Sales ratio NUVB's Sales per Employee NUVB's Asset Turnover Ratio
NUVB's Net Margin NUVB's Pb Price to Book ratio NUVB's Financial Strength Ratios NUVB's Dividend Payout Ratio
Date modified: 2026-09-08T01:22:06+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Ligand Pharmaceuticals Incorporated  6,181,744.68 $ 290.542  Million 47 
Anika Therapeutics Inc   5,779,523.81 $ 121.370  Million 21 
Xeris Biopharma Holdings Inc   5,160,215.38 $ 335.414  Million 65 
P3 Health Partners Inc   4,696,368.75 $ 1,502.838  Million 320 
Nuvation Bio Inc   3,943,046.51 $ 169.551  Million 43 
Halozyme Therapeutics Inc   3,933,186.76 $ 1,663.738  Million 423 
Ironwood Pharmaceuticals inc   3,893,160.00 $ 389.316  Million 100 
Community Health Systems Inc   3,865,483.87 $ 11,983.000  Million 3,100 
Vaxart Inc   3,739,446.15 $ 243.064  Million 65 
Illumina Inc   3,510,156.25 $ 4,493.000  Million 1,280 
Harmony Biosciences Holdings inc   3,277,102.39 $ 960.191  Million 293 
Therapeuticsmd Inc   3,270,000.00 $ 3.270  Million 1 
Amgen Inc   2,930,384.62 $ 38,095.000  Million 13,000 
Innoviva Inc   2,645,471.70 $ 420.630  Million 159 
Aurinia Pharmaceuticals Inc   2,433,648.44 $ 311.507  Million 128 
Eton Pharmaceuticals Inc   2,392,704.55 $ 105.279  Million 44 
Cormedix Inc   2,366,196.28 $ 451.943  Million 191 
Sarepta Therapeutics Inc   2,364,483.83 $ 1,974.344  Million 835 
United Therapeutics Corporation  2,253,214.29 $ 3,154.500  Million 1,400 
Biocryst Pharmaceuticals Inc   2,162,328.74 $ 940.613  Million 435 
Elite Pharmaceuticals Inc   2,155,839.86 $ 140.130  Million 65 
Protagonist Therapeutics inc   2,136,303.03 $ 281.992  Million 132 
Exelixis Inc   2,123,731.47 $ 2,435.920  Million 1,147 
Zevra Therapeutics Inc   2,112,377.05 $ 128.855  Million 61 
Liquidia Corporation  2,087,532.41 $ 450.907  Million 216 
Tg Therapeutics Inc   2,003,849.62 $ 799.536  Million 399 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.